Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Identification of Graphic Markers of Neurocognitive Disorders Such as Primary Progressive Aphasia (PPA) and Early-stage Alzheimer's Disease (AD) (MG)
Authors not listed
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal · 2022
Abstract
The diagnosis of neurocognitive disorders such as early Alzheimer's disease (AD) or primary progressive aphasia (PPA) is particularly difficult and constantly evolving, often leading to diagnostic erraticity. However, several studies have shown that graphic parameters are affected in people with moderate to severe Alzheimer's disease. The use of new technologies in the study and analysis of the abilities of people with neurodegenerative diseases is increasingly recommended. The use of a digital tablet with a stylus makes it possible to objectivize the kinematic parameters of writing (pressure, inclination, speed, jerk, time of writing task) and thus would allow a low-cost diffusion of this technology in particular by including it in already existing screening batteries.
The overall objective of the project is to characterize and compare the graphical markers of a writing task, either language-based (writing words, non-words, sentences) or non-language-based (drawing shapes), in patients with PPA, early-stage Alzheimer's disease (i.e., at the stage of minor neurocognitive disorders and major neurocognitive disorders at the beginning of the disease), and in people with no cognitive disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Anonymous. (2022). Identification of Graphic Markers of Neurocognitive Disorders Such as Primary Progressive Aphasia (PPA) and Early-stage Alzheimer's Disease (AD) (MG). <em>Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal</em>. https://clinicaltrials.gov/study/NCT05537688
Vancouver
Anonymous. Identification of Graphic Markers of Neurocognitive Disorders Such as Primary Progressive Aphasia (PPA) and Early-stage Alzheimer's Disease (AD) (MG). Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal. 2022.
BibTeX
@misc{anon2022Identi,
title = {Identification of Graphic Markers of Neurocognitive Disorders Such as Primary Progressive Aphasia (PPA) and Early-stage Alzheimer's Disease (AD) (MG)},
author = {Anonymous},
journal = {Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
US Department of Veterans Affairs 1999
Open access · US-GOV
Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Archives of Medical Research 2001
Preprint · OA
The Molecular Bases of Alzheimer's Disease and Other Neurodegenerative Disorders
Centre Hospitalier de Saint-Denis 2022
Open access · US-GOV